Skip to main content
NCBI home page
Canadian Journal of Veterinary Research logoLink to Canadian Journal of Veterinary Research
. 1996 Jul;60(3):172–178.

Cardiorespiratory effects of a 5HT2 antagonist (R51703) in awake and anesthetized dogs.

T J Doherty 1, W N McDonell 1, D H Dyson 1, W D Black 1
PMCID: PMC1263829  PMID: 8809379

Abstract

To investigate cardiorespiratory effects of an experimental 5-hydroxytryptamine receptor antagonist (R51703) with sedative properties, intramuscular doses of the drug were studied in 6 awake dogs of mixed breed, and in 6 anesthetized beagles. Two doses (0.2 and 0.4 mg/kg) of R51703 and a saline control were studied in the awake dogs using a randomized crossover trial. Subsequently, the higher dose of R51703 was included as a component of halothane anesthesia to determine whether the halothane sparing effect of R51703 produced a beneficial alteration of hemodynamic function. Data were obtained at equipotent halothane/R51703 (H/R) and halothane/saline (H/S) doses equivalent to 1.0, 1.5 and 2.0 MAC. In awake dogs, heart rates tended to be lower in dogs sedated with R51703, significantly so at 30 min for both doses, and at 90 and 120 min for the 0.2 and 0.4 mg/kg doses, respectively (P < 0.05). The cardiac index (CI) was lower at 60 min with both doses compared to the saline control group. Both doses of R51703 reduced mean blood pressure at 30, 90 and 120 min, and diastolic pressure at 30 and 90 min after administration; however, systolic blood pressure (SBP) was not altered. Overall, the cardiovascular alterations were minimal in conscious dogs and there was no evidence of respiratory depression. In the anesthetized dogs, at equipotent MAC, CI tended to be lower with H/R than with H/S, though the difference was not significant. Heart rate and stroke volume index also tended to be lower in the dogs treated with R51703, while systemic vascular resistance tended to be higher: these changes were not significant. Mean and SBP were higher at each MAC multiple in the H/R group. It was concluded that the halothane sparing effect of R51703 did not substantially improve hemodynamic function compared to the use of halothane alone at equipotent doses.

Full text

PDF
172

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bolt G. R., Saxena P. R. Cardiovascular profile and hypotensive mechanism of ketanserin in the rabbit. Hypertension. 1985 Jul-Aug;7(4):499–506. doi: 10.1161/01.hyp.7.4.499. [DOI] [PubMed] [Google Scholar]
  2. Boyd C. J., McDonell W. N., Valliant A. Comparative hemodynamic effects of halothane and halothane-acepromazine at equipotent doses in dogs. Can J Vet Res. 1991 Apr;55(2):107–112. [PMC free article] [PubMed] [Google Scholar]
  3. Brodde O. E. 5-Hydroxytryptamine-receptor subtypes. Clin Physiol Biochem. 1990;8 (Suppl 3):19–27. [PubMed] [Google Scholar]
  4. Cohen M. L., Fuller R. W., Kurz K. D. Evidence that blood pressure reduction by serotonin antagonists is related to alpha receptor blockade in spontaneously hypertensive rats. Hypertension. 1983 Sep-Oct;5(5):676–681. doi: 10.1161/01.hyp.5.5.676. [DOI] [PubMed] [Google Scholar]
  5. Degryse A. D., Ooms L. A. Clinical evaluation of R 51163, a new sedative in cattle. J Vet Pharmacol Ther. 1986 Dec;9(4):376–384. doi: 10.1111/j.1365-2885.1986.tb00058.x. [DOI] [PubMed] [Google Scholar]
  6. Distler A. Clinical aspects during therapy with the serotonin antagonist ketanserin. Clin Physiol Biochem. 1990;8 (Suppl 3):64–80. [PubMed] [Google Scholar]
  7. Doherty T. J., McDonell W. N., Dyson D. H., Black W. D., Valliant A. E. The effect of a 5-hydroxytryptamine antagonist (R51703) on halothane. MAC in the dog. J Vet Pharmacol Ther. 1995 Apr;18(2):153–155. doi: 10.1111/j.1365-2885.1995.tb00570.x. [DOI] [PubMed] [Google Scholar]
  8. Doherty T. J., Valverde A., Valliant A. E. Evaluation of sedative R51703 in cattle: effects on cardiorespiratory functions and rumen contraction rate. Can J Vet Res. 1988 Oct;52(4):481–483. [PMC free article] [PubMed] [Google Scholar]
  9. Farver T. B., Haskins S. C., Patz J. D. Cardiopulmonary effects of acepromazine and of the subsequent administration of ketamine in the dog. Am J Vet Res. 1986 Mar;47(3):631–635. [PubMed] [Google Scholar]
  10. Fozard J. R. Mechanism of the hypotensive effect of ketanserin. J Cardiovasc Pharmacol. 1982 Sep-Oct;4(5):829–838. doi: 10.1097/00005344-198209000-00020. [DOI] [PubMed] [Google Scholar]
  11. Furukawa Y., Saegusa K., Ogiwara Y., Chiba S. Effects of ketanserin on the pacemaker activity and contractility in the isolated, blood-perfused dog atrium. J Cardiovasc Pharmacol. 1986 Sep-Oct;8(5):967–972. doi: 10.1097/00005344-198609000-00013. [DOI] [PubMed] [Google Scholar]
  12. Hall R. I., Murphy M. R., Hug C. C., Jr The enflurane sparing effect of sufentanil in dogs. Anesthesiology. 1987 Oct;67(4):518–525. doi: 10.1097/00000542-198710000-00013. [DOI] [PubMed] [Google Scholar]
  13. Haskins S. C., Farver T. B., Patz J. D. Cardiovascular changes in dogs given diazepam and diazepam-ketamine. Am J Vet Res. 1986 Apr;47(4):795–798. [PubMed] [Google Scholar]
  14. Haskins S. C., Patz J. D., Farver T. B. Xylazine and xylazine-ketamine in dogs. Am J Vet Res. 1986 Mar;47(3):636–641. [PubMed] [Google Scholar]
  15. Heard D. J., Webb A. I., Daniels R. T. Effect of acepromazine on the anesthetic requirement of halothane in the dog. Am J Vet Res. 1986 Oct;47(10):2113–2115. [PubMed] [Google Scholar]
  16. Hsu W. H., Lu Z. X., Hembrough F. B. Effect of xylazine on heart rate and arterial blood pressure in conscious dogs, as influenced by atropine, 4-aminopyridine, doxapram, and yohimbine. J Am Vet Med Assoc. 1985 Jan 15;186(2):153–156. [PubMed] [Google Scholar]
  17. Jacobson J. D., McGrath C. J., Smith E. P. Cardiorespiratory effects of induction and maintenance of anesthesia with ketamine-midazolam combination, with and without prior administration of butorphanol or oxymorphone. Am J Vet Res. 1994 Apr;55(4):543–550. [PubMed] [Google Scholar]
  18. McCall R. B., Schuette M. R. Evidence for an alpha-1 receptor-mediated central sympathoinhibitory action of ketanserin. J Pharmacol Exp Ther. 1984 Mar;228(3):704–710. [PubMed] [Google Scholar]
  19. Muir W. W., 3rd, Bednarski L., Bednarski R. Thiamylal- and halothane-sparing effect of diazepam in dogs. J Vet Pharmacol Ther. 1991 Mar;14(1):46–50. doi: 10.1111/j.1365-2885.1991.tb00803.x. [DOI] [PubMed] [Google Scholar]
  20. Murphy M. R., Hug C. C., Jr The anesthetic potency of fentanyl in terms of its reduction of enflurane MAC. Anesthesiology. 1982 Dec;57(6):485–488. doi: 10.1097/00000542-198212000-00009. [DOI] [PubMed] [Google Scholar]
  21. Richer C., Scalbert E., Doussau M. P., Duhaze P., Giudicelli J. F. Ketanserin: systemic and regional hemodynamics in spontaneously hypertensive rats. Role of alpha 1-adrenoceptor blockade. Eur J Pharmacol. 1987 Jul 2;139(1):31–42. doi: 10.1016/0014-2999(87)90494-8. [DOI] [PubMed] [Google Scholar]
  22. Smith N. T., Calverley R. K., Prys-Roberts C., Eger E. I., 2nd, Jones C. W. Impact of nitrous oxide on the circulation during enflurane anesthesia in man. Anesthesiology. 1978 May;48(5):345–349. doi: 10.1097/00000542-197805000-00008. [DOI] [PubMed] [Google Scholar]
  23. Stepien R. L., Bonagura J. D., Bednarski R. M., Muir W. W., 3rd Cardiorespiratory effects of acepromazine maleate and buprenorphine hydrochloride in clinically normal dogs. Am J Vet Res. 1995 Jan;56(1):78–84. [PubMed] [Google Scholar]
  24. Tranquilli W. J., Thurmon J. C., Corbin J. E., Benson G. J., Davis L. E. Halothane-sparing effect of xylazine in dogs and subsequent reversal with tolazoline. J Vet Pharmacol Ther. 1984 Mar;7(1):23–28. doi: 10.1111/j.1365-2885.1984.tb00874.x. [DOI] [PubMed] [Google Scholar]
  25. Wagner A. E., Bednarski R. M., Muir W. W., 3rd Hemodynamic effects of carbon dioxide during intermittent positive-pressure ventilation in horses. Am J Vet Res. 1990 Dec;51(12):1922–1929. [PubMed] [Google Scholar]
  26. van Zwieten P. A., Blauw G. J., van Brummelen P. Pathophysiological and pharmacotherapeutic aspects of serotonin and serotonergic drugs. Clin Physiol Biochem. 1990;8 (Suppl 3):1–18. [PubMed] [Google Scholar]

Articles from Canadian Journal of Veterinary Research are provided here courtesy of Canadian Veterinary Medical Association

RESOURCES